The observation that FG-3019 exhibited more significant anti-cancer effect in vivo than in vitro suggests that matricellular proteins like CTGF may require distinct microenvironmental factors or conditions that are difficult to be replicated in cell culture experiments. The gene discussed is CCN2; the disease is cancer.